These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 23303344
1. Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism. Lavine JA, Sang Y, Wang S, Ip MS, Sheibani N. JAMA Ophthalmol; 2013 Mar; 131(3):376-82. PubMed ID: 23303344 [Abstract] [Full Text] [Related]
2. β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression. Lavine JA, Farnoodian M, Wang S, Darjatmoko SR, Wright LS, Gamm DM, Ip MS, Sorenson CM, Sheibani N. Invest Ophthalmol Vis Sci; 2017 Jan 01; 58(1):299-308. PubMed ID: 28114591 [Abstract] [Full Text] [Related]
3. Propranolol Attenuates Proangiogenic Activity of Mononuclear Phagocytes: Implication in Choroidal Neovascularization. Omri S, Tahiri H, Pierre WC, Desjarlais M, Lahaie I, Loiselle SE, Rezende F, Lodygensky G, Hebert TE, Ong H, Chemtob S. Invest Ophthalmol Vis Sci; 2019 Nov 01; 60(14):4632-4642. PubMed ID: 31682714 [Abstract] [Full Text] [Related]
4. TNF-α mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent β-catenin activation. Wang H, Han X, Wittchen ES, Hartnett ME. Mol Vis; 2016 Nov 01; 22():116-28. PubMed ID: 26900328 [Abstract] [Full Text] [Related]
5. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system. Hara C, Kasai A, Gomi F, Satooka T, Sakimoto S, Nakai K, Yoshioka Y, Yamamuro A, Maeda S, Nishida K. Invest Ophthalmol Vis Sci; 2013 Jun 21; 54(6):4321-9. PubMed ID: 23722395 [Abstract] [Full Text] [Related]
6. Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells. Jiang H, Wu M, Liu Y, Song L, Li S, Wang X, Zhang YF, Fang J, Wu S. J Neurochem; 2017 Nov 21; 143(3):375-388. PubMed ID: 28892569 [Abstract] [Full Text] [Related]
7. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Koto T, Nagai N, Mochimaru H, Kurihara T, Izumi-Nagai K, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Oike Y, Ishida S. Invest Ophthalmol Vis Sci; 2007 Sep 21; 48(9):4328-34. PubMed ID: 17724224 [Abstract] [Full Text] [Related]
8. Focal adhesion kinase signaling pathway participates in the formation of choroidal neovascularization and regulates the proliferation and migration of choroidal microvascular endothelial cells by acting through HIF-1 and VEGF expression in RPE cells. Zhu J, Wang YS, Zhang J, Zhao W, Yang XM, Li X, Jiang TS, Yao LB. Exp Eye Res; 2009 May 21; 88(5):910-8. PubMed ID: 19111720 [Abstract] [Full Text] [Related]
9. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor. Wakusawa R, Abe T, Sato H, Sonoda H, Sato M, Mitsuda Y, Takakura T, Fukushima T, Onami H, Nagai N, Ishikawa Y, Nishida K, Sato Y. Invest Ophthalmol Vis Sci; 2011 May 17; 52(6):3272-80. PubMed ID: 21345982 [Abstract] [Full Text] [Related]
10. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin. Nagai N, Oike Y, Izumi-Nagai K, Koto T, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Ishida S. Invest Ophthalmol Vis Sci; 2007 May 17; 48(5):2321-6. PubMed ID: 17460297 [Abstract] [Full Text] [Related]
11. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA. Gu L, Chen H, Tuo J, Gao X, Chen L. Exp Eye Res; 2010 Sep 17; 91(3):433-9. PubMed ID: 20599960 [Abstract] [Full Text] [Related]
12. Monocyte-Derived Macrophages Are Necessary for Beta-Adrenergic Receptor-Driven Choroidal Neovascularization Inhibition. Droho S, Cuda CM, Perlman H, Lavine JA. Invest Ophthalmol Vis Sci; 2019 Dec 02; 60(15):5059-5069. PubMed ID: 31800964 [Abstract] [Full Text] [Related]
13. Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization. Yoshikawa N, Noda K, Ozawa Y, Tsubota K, Mashima Y, Ishida S. Mol Vis; 2012 Dec 02; 18():593-600. PubMed ID: 22419852 [Abstract] [Full Text] [Related]
14. Effects of dioxin on vascular endothelial growth factor (VEGF) production in the retina associated with choroidal neovascularization. Takeuchi A, Takeuchi M, Oikawa K, Sonoda KH, Usui Y, Okunuki Y, Takeda A, Oshima Y, Yoshida K, Usui M, Goto H, Kuroda M. Invest Ophthalmol Vis Sci; 2009 Jul 02; 50(7):3410-6. PubMed ID: 19182260 [Abstract] [Full Text] [Related]
15. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist. Mizutani T, Ashikari M, Tokoro M, Nozaki M, Ogura Y. Invest Ophthalmol Vis Sci; 2013 Feb 28; 54(2):1564-72. PubMed ID: 23404125 [Abstract] [Full Text] [Related]
16. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA. Ashikari M, Tokoro M, Itaya M, Nozaki M, Ogura Y. Invest Ophthalmol Vis Sci; 2010 Jul 28; 51(7):3820-4. PubMed ID: 20130283 [Abstract] [Full Text] [Related]
17. Thy-1 Regulates VEGF-Mediated Choroidal Endothelial Cell Activation and Migration: Implications in Neovascular Age-Related Macular Degeneration. Wang H, Han X, Kunz E, Hartnett ME. Invest Ophthalmol Vis Sci; 2016 Oct 01; 57(13):5525-5534. PubMed ID: 27768790 [Abstract] [Full Text] [Related]
18. Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization. Sengupta N, Afzal A, Caballero S, Chang KH, Shaw LC, Pang JJ, Bond VC, Bhutto I, Baba T, Lutty GA, Grant MB. Invest Ophthalmol Vis Sci; 2010 May 01; 51(5):2697-704. PubMed ID: 20007826 [Abstract] [Full Text] [Related]
19. Inhibition of RACK1 ameliorates choroidal neovascularization formation in vitro and in vivo. Liu X, Zhu M, Yang X, Wang Y, Qin B, Cui C, Chen H, Sang A. Exp Mol Pathol; 2016 Jun 01; 100(3):451-9. PubMed ID: 27112838 [Abstract] [Full Text] [Related]
20. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin. Tomida D, Nishiguchi KM, Kataoka K, Yasuma TR, Iwata E, Uetani R, Kachi S, Terasaki H. Invest Ophthalmol Vis Sci; 2011 May 16; 52(6):3193-9. PubMed ID: 21296829 [Abstract] [Full Text] [Related] Page: [Next] [New Search]